Lower Extremity Neuromuscular Assessment in Children with Cerebral Palsy
Launched by UNIVERSITY OF THESSALY · Oct 29, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Lower Extremity Neuromuscular Assessment in Children with Cerebral Palsy," is focused on understanding how well certain devices can measure muscle strength and activity in the legs of children with cerebral palsy (CP). The study aims to see how reliable two specific tools are: the K-Pull dynamometer, which measures force, and the K-Myo sensor, which checks how active the muscles are without needing any invasive procedures. Researchers will look at children with different levels of mobility and compare their muscle activity, strength, and tone to better understand how these factors relate to each other.
To participate in this study, children must be between 5 and 16 years old and have spastic cerebral palsy, specifically classified at levels I to III on the GMFCS scale, meaning they have some ability to move and walk, either independently or with assistance. They should be able to follow simple instructions. However, children who have had certain treatments affecting muscle function, have sustained injuries, or have difficulty cooperating may not be eligible. Participants can expect a supportive environment where their muscle activity will be assessed through non-invasive methods, contributing valuable information to improve care for children with CP.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • children with spastic type cerebral palsy (CP),
- • aged between 5 and 16 years,
- • classified at GMFCS levels I to III,
- • voluntary motor control,
- • ambulatory, with or without the use of mobility aids,
- • can understand and execute verbal commands.
- Exclusion Criteria:
- • have previously undergone interventions that affect neuromuscular performance (such as surgery or botulinum toxin injections)
- • have sustained an injury,
- • demonstrate a low level of compliance.
About University Of Thessaly
The University of Thessaly is a distinguished academic institution located in Greece, recognized for its commitment to advancing medical research and education. With a strong emphasis on interdisciplinary collaboration, the university actively engages in clinical trials aimed at improving healthcare outcomes and fostering innovation in medical practices. Its dedicated research teams, equipped with state-of-the-art facilities and expertise across various fields, strive to contribute valuable insights to the scientific community while prioritizing patient safety and ethical standards in all clinical endeavors.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lamia, Phthiotis, Greece
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported